Home/GeneCentric Therapeutics/Kirk Beebe, PhD

KB

Kirk Beebe, PhD

Chief Scientific Officer

GeneCentric Therapeutics

Therapeutic Areas

GeneCentric Therapeutics Pipeline

Drug	Indication	Phase
PurIST®	Pancreatic Ductal Adenocarcinoma (PDAC)	Commercial
GenomicsNext™ Platform	Oncology (Multiple Tumor Types)	Development/Discovery

Leadership Team at GeneCentric Therapeutics

Michael V. Milburn, PhD

Chief Executive Officer and President

View full GeneCentric Therapeutics profile